✦ LIBER ✦

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

✍ Scribed by Jacobson, I.; Pockros, P.J.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJesus, E.; Haas, F.; Martorell, C.; Pruitt, R.; Purohit, V.; Srinivasan, S.; Jagannatha, S.; Rana, K.; Hammond, J.

Book ID: 122706379
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 51 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(10)61196-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1

✍ Jacobson, I.; Pockros, P.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

[649] CPG 10101 (ACTILON) IN COMBINATION

[649] CPG 10101 (ACTILON) IN COMBINATION WITH PEGYLATED INTERFERON AND/OR RIBAVIRIN IN CHRONIC HCV GENOTYPE 1 INFECTED PATIENTS WITH PRIOR RELAPSED RESPONSE: WEEK 48 DATA

✍ M.L. Shiftman; R. Ghalib; E. Lawitz; B. Freilich; S.C. Gordon; P.Y. Kwo; T.R. Ri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Faldaprevir combined with pegylated inte

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

✍ Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Treatment of Chronic Hepatitis C Genotyp

Treatment of Chronic Hepatitis C Genotype 1 with Pegylated Interferon and Ribavirin for 36 Weeks in Patients with Early Virological Response

✍ Sood, Ajit; Midha, Vandana; Goyal, Omesh; Sood, Neena; Sharma, Suresh 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 63 KB

P724 VIROLOGICAL RESPONSE IN TREATMENT-N

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

✍ Asselah, T.; Jensen, D.M.; Foster, G.R.; Sulkowski, M.S.; Ouzan, D.; Morano, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1193 A DESCRIPTION OF VIROLOGIC ESCAPE I

1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B

✍ McPhee, F.; Hernandez, D.; Yu, F.; Ueland, J.; Chayama, K.; Toyota, J.; Izumi, N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB